nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—CA4—epilepsy syndrome	0.214	1	CbGaD
Metolazone—Indapamide—Oxcarbazepine—epilepsy syndrome	0.143	0.582	CrCrCtD
Metolazone—Chlorthalidone—Clonazepam—epilepsy syndrome	0.103	0.419	CrCrCtD
Metolazone—CA5B—Lacosamide—epilepsy syndrome	0.0304	0.079	CbGbCtD
Metolazone—CA9—Lacosamide—epilepsy syndrome	0.0261	0.0678	CbGbCtD
Metolazone—CA5A—Acetazolamide—epilepsy syndrome	0.024	0.0623	CbGbCtD
Metolazone—CA4—Lacosamide—epilepsy syndrome	0.023	0.0596	CbGbCtD
Metolazone—CA5A—Zonisamide—epilepsy syndrome	0.0222	0.0577	CbGbCtD
Metolazone—CA5B—Acetazolamide—epilepsy syndrome	0.0209	0.0543	CbGbCtD
Metolazone—CA7—Acetazolamide—epilepsy syndrome	0.0209	0.0543	CbGbCtD
Metolazone—CA5B—Zonisamide—epilepsy syndrome	0.0194	0.0503	CbGbCtD
Metolazone—CA7—Zonisamide—epilepsy syndrome	0.0194	0.0503	CbGbCtD
Metolazone—CA12—Acetazolamide—epilepsy syndrome	0.018	0.0466	CbGbCtD
Metolazone—CA9—Acetazolamide—epilepsy syndrome	0.018	0.0466	CbGbCtD
Metolazone—CA12—Zonisamide—epilepsy syndrome	0.0166	0.0432	CbGbCtD
Metolazone—CA9—Zonisamide—epilepsy syndrome	0.0166	0.0432	CbGbCtD
Metolazone—CA5A—Topiramate—epilepsy syndrome	0.0162	0.042	CbGbCtD
Metolazone—CA4—Acetazolamide—epilepsy syndrome	0.0158	0.041	CbGbCtD
Metolazone—CA4—Zonisamide—epilepsy syndrome	0.0146	0.038	CbGbCtD
Metolazone—CA7—Topiramate—epilepsy syndrome	0.0141	0.0366	CbGbCtD
Metolazone—CA5B—Topiramate—epilepsy syndrome	0.0141	0.0366	CbGbCtD
Metolazone—CA9—Topiramate—epilepsy syndrome	0.0121	0.0314	CbGbCtD
Metolazone—CA12—Topiramate—epilepsy syndrome	0.0121	0.0314	CbGbCtD
Metolazone—CA4—Topiramate—epilepsy syndrome	0.0107	0.0277	CbGbCtD
Metolazone—Quinethazone—SLC12A2—epilepsy syndrome	0.000655	0.287	CrCbGaD
Metolazone—CA4—ganglion—epilepsy syndrome	0.00046	0.091	CbGeAlD
Metolazone—CA4—hindbrain—epilepsy syndrome	0.000349	0.069	CbGeAlD
Metolazone—Methyclothiazide—CA4—epilepsy syndrome	0.000344	0.151	CrCbGaD
Metolazone—Benzthiazide—CA4—epilepsy syndrome	0.000334	0.146	CrCbGaD
Metolazone—Chlorothiazide—CA4—epilepsy syndrome	0.000331	0.145	CrCbGaD
Metolazone—Indapamide—CA4—epilepsy syndrome	0.000331	0.145	CrCbGaD
Metolazone—CA7—midbrain—epilepsy syndrome	0.000317	0.0627	CbGeAlD
Metolazone—CA12—forebrain—epilepsy syndrome	0.000312	0.0617	CbGeAlD
Metolazone—CA12—telencephalon—epilepsy syndrome	0.000287	0.0567	CbGeAlD
Metolazone—Chlorthalidone—CA4—epilepsy syndrome	0.000285	0.125	CrCbGaD
Metolazone—CA7—cerebellum—epilepsy syndrome	0.000245	0.0485	CbGeAlD
Metolazone—CA9—cerebellum—epilepsy syndrome	0.000215	0.0426	CbGeAlD
Metolazone—CA4—brainstem—epilepsy syndrome	0.0002	0.0396	CbGeAlD
Metolazone—CA7—brain—epilepsy syndrome	0.000199	0.0394	CbGeAlD
Metolazone—CA4—forebrain—epilepsy syndrome	0.000193	0.0382	CbGeAlD
Metolazone—CA12—head—epilepsy syndrome	0.000179	0.0353	CbGeAlD
Metolazone—CA4—telencephalon—epilepsy syndrome	0.000178	0.0351	CbGeAlD
Metolazone—CA12—nervous system—epilepsy syndrome	0.000169	0.0335	CbGeAlD
Metolazone—CA12—central nervous system—epilepsy syndrome	0.000163	0.0322	CbGeAlD
Metolazone—CA5B—head—epilepsy syndrome	0.00016	0.0317	CbGeAlD
Metolazone—CA5B—nervous system—epilepsy syndrome	0.000152	0.03	CbGeAlD
Metolazone—CA5B—central nervous system—epilepsy syndrome	0.000146	0.0289	CbGeAlD
Metolazone—CA4—medulla oblongata—epilepsy syndrome	0.00014	0.0276	CbGeAlD
Metolazone—CA12—brain—epilepsy syndrome	0.000129	0.0256	CbGeAlD
Metolazone—CA4—midbrain—epilepsy syndrome	0.000128	0.0252	CbGeAlD
Metolazone—CA4—spinal cord—epilepsy syndrome	0.000124	0.0246	CbGeAlD
Metolazone—CA5B—brain—epilepsy syndrome	0.000116	0.023	CbGeAlD
Metolazone—CA4—head—epilepsy syndrome	0.000111	0.0219	CbGeAlD
Metolazone—CA4—nervous system—epilepsy syndrome	0.000105	0.0207	CbGeAlD
Metolazone—CA4—central nervous system—epilepsy syndrome	0.000101	0.02	CbGeAlD
Metolazone—CA4—cerebellum—epilepsy syndrome	9.87e-05	0.0195	CbGeAlD
Metolazone—CA4—brain—epilepsy syndrome	8.02e-05	0.0158	CbGeAlD
Metolazone—Pruritus—Zonisamide—epilepsy syndrome	4.17e-05	0.000437	CcSEcCtD
Metolazone—Hypersensitivity—Phenytoin—epilepsy syndrome	4.16e-05	0.000435	CcSEcCtD
Metolazone—Flatulence—Gabapentin—epilepsy syndrome	4.14e-05	0.000434	CcSEcCtD
Metolazone—Urticaria—Lamotrigine—epilepsy syndrome	4.14e-05	0.000433	CcSEcCtD
Metolazone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.000433	CcSEcCtD
Metolazone—Malaise—Pregabalin—epilepsy syndrome	4.14e-05	0.000433	CcSEcCtD
Metolazone—Nausea—Propofol—epilepsy syndrome	4.13e-05	0.000433	CcSEcCtD
Metolazone—Tension—Gabapentin—epilepsy syndrome	4.13e-05	0.000432	CcSEcCtD
Metolazone—Vomiting—Fosphenytoin—epilepsy syndrome	4.13e-05	0.000432	CcSEcCtD
Metolazone—Diarrhoea—Felbamate—epilepsy syndrome	4.12e-05	0.000432	CcSEcCtD
Metolazone—Vertigo—Pregabalin—epilepsy syndrome	4.12e-05	0.000431	CcSEcCtD
Metolazone—Abdominal pain—Lamotrigine—epilepsy syndrome	4.12e-05	0.000431	CcSEcCtD
Metolazone—Dysgeusia—Gabapentin—epilepsy syndrome	4.12e-05	0.000431	CcSEcCtD
Metolazone—Dizziness—Diazepam—epilepsy syndrome	4.12e-05	0.000431	CcSEcCtD
Metolazone—Syncope—Pregabalin—epilepsy syndrome	4.11e-05	0.00043	CcSEcCtD
Metolazone—Leukopenia—Pregabalin—epilepsy syndrome	4.11e-05	0.00043	CcSEcCtD
Metolazone—Rash—Fosphenytoin—epilepsy syndrome	4.09e-05	0.000428	CcSEcCtD
Metolazone—Dermatitis—Fosphenytoin—epilepsy syndrome	4.09e-05	0.000428	CcSEcCtD
Metolazone—Nervousness—Gabapentin—epilepsy syndrome	4.08e-05	0.000427	CcSEcCtD
Metolazone—Asthenia—Clonazepam—epilepsy syndrome	4.08e-05	0.000427	CcSEcCtD
Metolazone—Back pain—Gabapentin—epilepsy syndrome	4.07e-05	0.000426	CcSEcCtD
Metolazone—Headache—Fosphenytoin—epilepsy syndrome	4.07e-05	0.000425	CcSEcCtD
Metolazone—Hepatitis—Topiramate—epilepsy syndrome	4.06e-05	0.000425	CcSEcCtD
Metolazone—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.05e-05	0.000424	CcSEcCtD
Metolazone—Palpitations—Pregabalin—epilepsy syndrome	4.05e-05	0.000424	CcSEcCtD
Metolazone—Asthenia—Phenytoin—epilepsy syndrome	4.05e-05	0.000424	CcSEcCtD
Metolazone—Nausea—Midazolam—epilepsy syndrome	4.04e-05	0.000423	CcSEcCtD
Metolazone—Muscle spasms—Gabapentin—epilepsy syndrome	4.04e-05	0.000423	CcSEcCtD
Metolazone—Diarrhoea—Zonisamide—epilepsy syndrome	4.04e-05	0.000422	CcSEcCtD
Metolazone—Loss of consciousness—Pregabalin—epilepsy syndrome	4.03e-05	0.000422	CcSEcCtD
Metolazone—Asthenia—Oxcarbazepine—epilepsy syndrome	4.03e-05	0.000422	CcSEcCtD
Metolazone—Pruritus—Clonazepam—epilepsy syndrome	4.02e-05	0.000421	CcSEcCtD
Metolazone—Vomiting—Vigabatrin—epilepsy syndrome	4.02e-05	0.000421	CcSEcCtD
Metolazone—Cough—Pregabalin—epilepsy syndrome	4e-05	0.000419	CcSEcCtD
Metolazone—Pruritus—Phenytoin—epilepsy syndrome	4e-05	0.000418	CcSEcCtD
Metolazone—Nausea—Levetiracetam—epilepsy syndrome	3.99e-05	0.000418	CcSEcCtD
Metolazone—Rash—Vigabatrin—epilepsy syndrome	3.99e-05	0.000417	CcSEcCtD
Metolazone—Dizziness—Felbamate—epilepsy syndrome	3.99e-05	0.000417	CcSEcCtD
Metolazone—Dermatitis—Vigabatrin—epilepsy syndrome	3.98e-05	0.000417	CcSEcCtD
Metolazone—Pruritus—Oxcarbazepine—epilepsy syndrome	3.97e-05	0.000416	CcSEcCtD
Metolazone—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.97e-05	0.000416	CcSEcCtD
Metolazone—Vision blurred—Gabapentin—epilepsy syndrome	3.96e-05	0.000415	CcSEcCtD
Metolazone—Headache—Vigabatrin—epilepsy syndrome	3.96e-05	0.000415	CcSEcCtD
Metolazone—Hypertension—Pregabalin—epilepsy syndrome	3.96e-05	0.000414	CcSEcCtD
Metolazone—Vomiting—Diazepam—epilepsy syndrome	3.96e-05	0.000414	CcSEcCtD
Metolazone—Anorexia—Valproic Acid—epilepsy syndrome	3.95e-05	0.000413	CcSEcCtD
Metolazone—Rash—Diazepam—epilepsy syndrome	3.93e-05	0.000411	CcSEcCtD
Metolazone—Dermatitis—Diazepam—epilepsy syndrome	3.92e-05	0.000411	CcSEcCtD
Metolazone—Arthralgia—Pregabalin—epilepsy syndrome	3.9e-05	0.000409	CcSEcCtD
Metolazone—Chest pain—Pregabalin—epilepsy syndrome	3.9e-05	0.000409	CcSEcCtD
Metolazone—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.9e-05	0.000408	CcSEcCtD
Metolazone—Dizziness—Zonisamide—epilepsy syndrome	3.9e-05	0.000408	CcSEcCtD
Metolazone—Headache—Diazepam—epilepsy syndrome	3.9e-05	0.000408	CcSEcCtD
Metolazone—Anxiety—Pregabalin—epilepsy syndrome	3.89e-05	0.000407	CcSEcCtD
Metolazone—Diarrhoea—Clonazepam—epilepsy syndrome	3.89e-05	0.000407	CcSEcCtD
Metolazone—Anaemia—Gabapentin—epilepsy syndrome	3.89e-05	0.000407	CcSEcCtD
Metolazone—Asthenia—Carbamazepine—epilepsy syndrome	3.87e-05	0.000405	CcSEcCtD
Metolazone—Agitation—Gabapentin—epilepsy syndrome	3.86e-05	0.000404	CcSEcCtD
Metolazone—Diarrhoea—Phenytoin—epilepsy syndrome	3.86e-05	0.000404	CcSEcCtD
Metolazone—Discomfort—Pregabalin—epilepsy syndrome	3.86e-05	0.000404	CcSEcCtD
Metolazone—Nausea—Fosphenytoin—epilepsy syndrome	3.85e-05	0.000403	CcSEcCtD
Metolazone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.84e-05	0.000402	CcSEcCtD
Metolazone—Erythema multiforme—Topiramate—epilepsy syndrome	3.84e-05	0.000402	CcSEcCtD
Metolazone—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.84e-05	0.000402	CcSEcCtD
Metolazone—Vomiting—Felbamate—epilepsy syndrome	3.83e-05	0.000401	CcSEcCtD
Metolazone—Dry mouth—Pregabalin—epilepsy syndrome	3.82e-05	0.0004	CcSEcCtD
Metolazone—Pruritus—Carbamazepine—epilepsy syndrome	3.81e-05	0.000399	CcSEcCtD
Metolazone—Rash—Felbamate—epilepsy syndrome	3.8e-05	0.000398	CcSEcCtD
Metolazone—Dermatitis—Felbamate—epilepsy syndrome	3.8e-05	0.000397	CcSEcCtD
Metolazone—Malaise—Gabapentin—epilepsy syndrome	3.79e-05	0.000397	CcSEcCtD
Metolazone—Tinnitus—Topiramate—epilepsy syndrome	3.79e-05	0.000397	CcSEcCtD
Metolazone—Vertigo—Gabapentin—epilepsy syndrome	3.78e-05	0.000395	CcSEcCtD
Metolazone—Headache—Felbamate—epilepsy syndrome	3.78e-05	0.000395	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.77e-05	0.000395	CcSEcCtD
Metolazone—Syncope—Gabapentin—epilepsy syndrome	3.77e-05	0.000395	CcSEcCtD
Metolazone—Leukopenia—Gabapentin—epilepsy syndrome	3.76e-05	0.000394	CcSEcCtD
Metolazone—Dizziness—Clonazepam—epilepsy syndrome	3.76e-05	0.000394	CcSEcCtD
Metolazone—Nausea—Vigabatrin—epilepsy syndrome	3.76e-05	0.000393	CcSEcCtD
Metolazone—Vomiting—Zonisamide—epilepsy syndrome	3.75e-05	0.000393	CcSEcCtD
Metolazone—Insomnia—Valproic Acid—epilepsy syndrome	3.74e-05	0.000392	CcSEcCtD
Metolazone—Asthenia—Lamotrigine—epilepsy syndrome	3.74e-05	0.000391	CcSEcCtD
Metolazone—Dizziness—Phenytoin—epilepsy syndrome	3.73e-05	0.000391	CcSEcCtD
Metolazone—Rash—Zonisamide—epilepsy syndrome	3.72e-05	0.000389	CcSEcCtD
Metolazone—Paraesthesia—Valproic Acid—epilepsy syndrome	3.72e-05	0.000389	CcSEcCtD
Metolazone—Palpitations—Gabapentin—epilepsy syndrome	3.72e-05	0.000389	CcSEcCtD
Metolazone—Dermatitis—Zonisamide—epilepsy syndrome	3.72e-05	0.000389	CcSEcCtD
Metolazone—Dizziness—Oxcarbazepine—epilepsy syndrome	3.71e-05	0.000389	CcSEcCtD
Metolazone—Nausea—Diazepam—epilepsy syndrome	3.7e-05	0.000387	CcSEcCtD
Metolazone—Loss of consciousness—Gabapentin—epilepsy syndrome	3.7e-05	0.000387	CcSEcCtD
Metolazone—Headache—Zonisamide—epilepsy syndrome	3.7e-05	0.000387	CcSEcCtD
Metolazone—Diarrhoea—Carbamazepine—epilepsy syndrome	3.69e-05	0.000386	CcSEcCtD
Metolazone—Pruritus—Lamotrigine—epilepsy syndrome	3.69e-05	0.000386	CcSEcCtD
Metolazone—Shock—Pregabalin—epilepsy syndrome	3.68e-05	0.000385	CcSEcCtD
Metolazone—Somnolence—Valproic Acid—epilepsy syndrome	3.68e-05	0.000385	CcSEcCtD
Metolazone—Cough—Gabapentin—epilepsy syndrome	3.67e-05	0.000384	CcSEcCtD
Metolazone—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.66e-05	0.000384	CcSEcCtD
Metolazone—Chills—Topiramate—epilepsy syndrome	3.65e-05	0.000382	CcSEcCtD
Metolazone—Dyspepsia—Valproic Acid—epilepsy syndrome	3.64e-05	0.000381	CcSEcCtD
Metolazone—Hypertension—Gabapentin—epilepsy syndrome	3.63e-05	0.00038	CcSEcCtD
Metolazone—Vomiting—Clonazepam—epilepsy syndrome	3.62e-05	0.000378	CcSEcCtD
Metolazone—Decreased appetite—Valproic Acid—epilepsy syndrome	3.6e-05	0.000377	CcSEcCtD
Metolazone—Vomiting—Phenytoin—epilepsy syndrome	3.59e-05	0.000376	CcSEcCtD
Metolazone—Rash—Clonazepam—epilepsy syndrome	3.59e-05	0.000375	CcSEcCtD
Metolazone—Dermatitis—Clonazepam—epilepsy syndrome	3.58e-05	0.000375	CcSEcCtD
Metolazone—Chest pain—Gabapentin—epilepsy syndrome	3.58e-05	0.000375	CcSEcCtD
Metolazone—Arthralgia—Gabapentin—epilepsy syndrome	3.58e-05	0.000375	CcSEcCtD
Metolazone—Nausea—Felbamate—epilepsy syndrome	3.58e-05	0.000375	CcSEcCtD
Metolazone—Vomiting—Oxcarbazepine—epilepsy syndrome	3.57e-05	0.000374	CcSEcCtD
Metolazone—Fatigue—Valproic Acid—epilepsy syndrome	3.57e-05	0.000374	CcSEcCtD
Metolazone—Anxiety—Gabapentin—epilepsy syndrome	3.57e-05	0.000373	CcSEcCtD
Metolazone—Anorexia—Pregabalin—epilepsy syndrome	3.57e-05	0.000373	CcSEcCtD
Metolazone—Dizziness—Carbamazepine—epilepsy syndrome	3.56e-05	0.000373	CcSEcCtD
Metolazone—Diarrhoea—Lamotrigine—epilepsy syndrome	3.56e-05	0.000373	CcSEcCtD
Metolazone—Headache—Clonazepam—epilepsy syndrome	3.56e-05	0.000373	CcSEcCtD
Metolazone—Rash—Phenytoin—epilepsy syndrome	3.56e-05	0.000373	CcSEcCtD
Metolazone—Dermatitis—Phenytoin—epilepsy syndrome	3.56e-05	0.000372	CcSEcCtD
Metolazone—Rash—Oxcarbazepine—epilepsy syndrome	3.54e-05	0.000371	CcSEcCtD
Metolazone—Pain—Valproic Acid—epilepsy syndrome	3.54e-05	0.000371	CcSEcCtD
Metolazone—Constipation—Valproic Acid—epilepsy syndrome	3.54e-05	0.000371	CcSEcCtD
Metolazone—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.54e-05	0.00037	CcSEcCtD
Metolazone—Headache—Phenytoin—epilepsy syndrome	3.54e-05	0.00037	CcSEcCtD
Metolazone—Discomfort—Gabapentin—epilepsy syndrome	3.54e-05	0.00037	CcSEcCtD
Metolazone—Headache—Oxcarbazepine—epilepsy syndrome	3.52e-05	0.000368	CcSEcCtD
Metolazone—Nausea—Zonisamide—epilepsy syndrome	3.5e-05	0.000367	CcSEcCtD
Metolazone—Dry mouth—Gabapentin—epilepsy syndrome	3.5e-05	0.000366	CcSEcCtD
Metolazone—Flatulence—Topiramate—epilepsy syndrome	3.49e-05	0.000365	CcSEcCtD
Metolazone—Tension—Topiramate—epilepsy syndrome	3.47e-05	0.000363	CcSEcCtD
Metolazone—Dysgeusia—Topiramate—epilepsy syndrome	3.46e-05	0.000363	CcSEcCtD
Metolazone—Dizziness—Lamotrigine—epilepsy syndrome	3.45e-05	0.000361	CcSEcCtD
Metolazone—Nervousness—Topiramate—epilepsy syndrome	3.44e-05	0.00036	CcSEcCtD
Metolazone—Vomiting—Carbamazepine—epilepsy syndrome	3.43e-05	0.000359	CcSEcCtD
Metolazone—Back pain—Topiramate—epilepsy syndrome	3.42e-05	0.000358	CcSEcCtD
Metolazone—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.41e-05	0.000357	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.41e-05	0.000357	CcSEcCtD
Metolazone—Muscle spasms—Topiramate—epilepsy syndrome	3.4e-05	0.000356	CcSEcCtD
Metolazone—Rash—Carbamazepine—epilepsy syndrome	3.4e-05	0.000356	CcSEcCtD
Metolazone—Dermatitis—Carbamazepine—epilepsy syndrome	3.4e-05	0.000355	CcSEcCtD
Metolazone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.39e-05	0.000354	CcSEcCtD
Metolazone—Insomnia—Pregabalin—epilepsy syndrome	3.39e-05	0.000354	CcSEcCtD
Metolazone—Nausea—Clonazepam—epilepsy syndrome	3.38e-05	0.000353	CcSEcCtD
Metolazone—Headache—Carbamazepine—epilepsy syndrome	3.38e-05	0.000353	CcSEcCtD
Metolazone—Shock—Gabapentin—epilepsy syndrome	3.38e-05	0.000353	CcSEcCtD
Metolazone—Paraesthesia—Pregabalin—epilepsy syndrome	3.36e-05	0.000352	CcSEcCtD
Metolazone—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.36e-05	0.000352	CcSEcCtD
Metolazone—Nausea—Phenytoin—epilepsy syndrome	3.35e-05	0.000351	CcSEcCtD
Metolazone—Nausea—Oxcarbazepine—epilepsy syndrome	3.34e-05	0.000349	CcSEcCtD
Metolazone—Vision blurred—Topiramate—epilepsy syndrome	3.33e-05	0.000349	CcSEcCtD
Metolazone—Somnolence—Pregabalin—epilepsy syndrome	3.33e-05	0.000348	CcSEcCtD
Metolazone—Vomiting—Lamotrigine—epilepsy syndrome	3.31e-05	0.000347	CcSEcCtD
Metolazone—Urticaria—Valproic Acid—epilepsy syndrome	3.29e-05	0.000344	CcSEcCtD
Metolazone—Rash—Lamotrigine—epilepsy syndrome	3.29e-05	0.000344	CcSEcCtD
Metolazone—Ill-defined disorder—Topiramate—epilepsy syndrome	3.28e-05	0.000344	CcSEcCtD
Metolazone—Dermatitis—Lamotrigine—epilepsy syndrome	3.28e-05	0.000344	CcSEcCtD
Metolazone—Abdominal pain—Valproic Acid—epilepsy syndrome	3.27e-05	0.000343	CcSEcCtD
Metolazone—Anorexia—Gabapentin—epilepsy syndrome	3.27e-05	0.000342	CcSEcCtD
Metolazone—Anaemia—Topiramate—epilepsy syndrome	3.27e-05	0.000342	CcSEcCtD
Metolazone—Headache—Lamotrigine—epilepsy syndrome	3.26e-05	0.000342	CcSEcCtD
Metolazone—Decreased appetite—Pregabalin—epilepsy syndrome	3.25e-05	0.000341	CcSEcCtD
Metolazone—Agitation—Topiramate—epilepsy syndrome	3.25e-05	0.00034	CcSEcCtD
Metolazone—Fatigue—Pregabalin—epilepsy syndrome	3.23e-05	0.000338	CcSEcCtD
Metolazone—Nausea—Carbamazepine—epilepsy syndrome	3.2e-05	0.000335	CcSEcCtD
Metolazone—Constipation—Pregabalin—epilepsy syndrome	3.2e-05	0.000335	CcSEcCtD
Metolazone—Pain—Pregabalin—epilepsy syndrome	3.2e-05	0.000335	CcSEcCtD
Metolazone—Malaise—Topiramate—epilepsy syndrome	3.19e-05	0.000334	CcSEcCtD
Metolazone—Vertigo—Topiramate—epilepsy syndrome	3.18e-05	0.000333	CcSEcCtD
Metolazone—Syncope—Topiramate—epilepsy syndrome	3.17e-05	0.000332	CcSEcCtD
Metolazone—Leukopenia—Topiramate—epilepsy syndrome	3.17e-05	0.000331	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.13e-05	0.000327	CcSEcCtD
Metolazone—Palpitations—Topiramate—epilepsy syndrome	3.13e-05	0.000327	CcSEcCtD
Metolazone—Loss of consciousness—Topiramate—epilepsy syndrome	3.11e-05	0.000325	CcSEcCtD
Metolazone—Insomnia—Gabapentin—epilepsy syndrome	3.1e-05	0.000325	CcSEcCtD
Metolazone—Nausea—Lamotrigine—epilepsy syndrome	3.09e-05	0.000324	CcSEcCtD
Metolazone—Cough—Topiramate—epilepsy syndrome	3.09e-05	0.000323	CcSEcCtD
Metolazone—Feeling abnormal—Pregabalin—epilepsy syndrome	3.08e-05	0.000323	CcSEcCtD
Metolazone—Paraesthesia—Gabapentin—epilepsy syndrome	3.08e-05	0.000323	CcSEcCtD
Metolazone—CA5B—Metabolism—ASAH1—epilepsy syndrome	3.06e-05	0.00059	CbGpPWpGaD
Metolazone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.06e-05	0.00032	CcSEcCtD
Metolazone—Hypertension—Topiramate—epilepsy syndrome	3.05e-05	0.00032	CcSEcCtD
Metolazone—Somnolence—Gabapentin—epilepsy syndrome	3.05e-05	0.000319	CcSEcCtD
Metolazone—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.05e-05	0.000319	CcSEcCtD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.05e-05	0.000587	CbGpPWpGaD
Metolazone—Dyspepsia—Gabapentin—epilepsy syndrome	3.02e-05	0.000316	CcSEcCtD
Metolazone—CA12—Metabolism—PPP1R3C—epilepsy syndrome	3.02e-05	0.000581	CbGpPWpGaD
Metolazone—CA12—Metabolism—GBE1—epilepsy syndrome	3.02e-05	0.000581	CbGpPWpGaD
Metolazone—CA9—Metabolism—ADK—epilepsy syndrome	3.02e-05	0.000581	CbGpPWpGaD
Metolazone—CA9—Metabolism—GLUD1—epilepsy syndrome	3.02e-05	0.000581	CbGpPWpGaD
Metolazone—CA9—Metabolism—PDXK—epilepsy syndrome	3.02e-05	0.000581	CbGpPWpGaD
Metolazone—CA9—Metabolism—FAR1—epilepsy syndrome	3.02e-05	0.000581	CbGpPWpGaD
Metolazone—CA9—Metabolism—L2HGDH—epilepsy syndrome	3.02e-05	0.000581	CbGpPWpGaD
Metolazone—CA9—Metabolism—CERS1—epilepsy syndrome	3.02e-05	0.000581	CbGpPWpGaD
Metolazone—Arthralgia—Topiramate—epilepsy syndrome	3.01e-05	0.000315	CcSEcCtD
Metolazone—Chest pain—Topiramate—epilepsy syndrome	3.01e-05	0.000315	CcSEcCtD
Metolazone—Anxiety—Topiramate—epilepsy syndrome	3e-05	0.000314	CcSEcCtD
Metolazone—CA4—Metabolism—COX3—epilepsy syndrome	2.99e-05	0.000575	CbGpPWpGaD
Metolazone—Decreased appetite—Gabapentin—epilepsy syndrome	2.98e-05	0.000312	CcSEcCtD
Metolazone—CA5B—Metabolism—STXBP1—epilepsy syndrome	2.98e-05	0.000574	CbGpPWpGaD
Metolazone—CA7—Metabolism—STXBP1—epilepsy syndrome	2.98e-05	0.000574	CbGpPWpGaD
Metolazone—Discomfort—Topiramate—epilepsy syndrome	2.98e-05	0.000311	CcSEcCtD
Metolazone—Urticaria—Pregabalin—epilepsy syndrome	2.97e-05	0.000311	CcSEcCtD
Metolazone—Asthenia—Valproic Acid—epilepsy syndrome	2.97e-05	0.000311	CcSEcCtD
Metolazone—CA5A—Metabolism—ALDH7A1—epilepsy syndrome	2.97e-05	0.000572	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CACNA1A—epilepsy syndrome	2.97e-05	0.000572	CbGpPWpGaD
Metolazone—Fatigue—Gabapentin—epilepsy syndrome	2.96e-05	0.00031	CcSEcCtD
Metolazone—Abdominal pain—Pregabalin—epilepsy syndrome	2.96e-05	0.00031	CcSEcCtD
Metolazone—Dry mouth—Topiramate—epilepsy syndrome	2.95e-05	0.000308	CcSEcCtD
Metolazone—Constipation—Gabapentin—epilepsy syndrome	2.94e-05	0.000307	CcSEcCtD
Metolazone—Pain—Gabapentin—epilepsy syndrome	2.94e-05	0.000307	CcSEcCtD
Metolazone—Pruritus—Valproic Acid—epilepsy syndrome	2.93e-05	0.000307	CcSEcCtD
Metolazone—CA7—Metabolism—ALAD—epilepsy syndrome	2.9e-05	0.000559	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALAD—epilepsy syndrome	2.9e-05	0.000559	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ST3GAL3—epilepsy syndrome	2.9e-05	0.000559	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NT5E—epilepsy syndrome	2.9e-05	0.000559	CbGpPWpGaD
Metolazone—CA7—Metabolism—NT5E—epilepsy syndrome	2.9e-05	0.000559	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ADSL—epilepsy syndrome	2.84e-05	0.000548	CbGpPWpGaD
Metolazone—Shock—Topiramate—epilepsy syndrome	2.84e-05	0.000297	CcSEcCtD
Metolazone—CA12—Metabolism—ASAH1—epilepsy syndrome	2.84e-05	0.000547	CbGpPWpGaD
Metolazone—Diarrhoea—Valproic Acid—epilepsy syndrome	2.83e-05	0.000296	CcSEcCtD
Metolazone—CA4—Metabolism—CACNA2D2—epilepsy syndrome	2.83e-05	0.000545	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC6A8—epilepsy syndrome	2.83e-05	0.000545	CbGpPWpGaD
Metolazone—CA4—Metabolism—PFKL—epilepsy syndrome	2.83e-05	0.000545	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLCO1A2—epilepsy syndrome	2.83e-05	0.000545	CbGpPWpGaD
Metolazone—CA4—Metabolism—KCNB1—epilepsy syndrome	2.83e-05	0.000545	CbGpPWpGaD
Metolazone—Feeling abnormal—Gabapentin—epilepsy syndrome	2.83e-05	0.000296	CcSEcCtD
Metolazone—Thrombocytopenia—Topiramate—epilepsy syndrome	2.83e-05	0.000296	CcSEcCtD
Metolazone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.81e-05	0.000294	CcSEcCtD
Metolazone—CA5A—Metabolism—GLUL—epilepsy syndrome	2.79e-05	0.000537	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALDH7A1—epilepsy syndrome	2.77e-05	0.000534	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CACNA1A—epilepsy syndrome	2.77e-05	0.000534	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALDH7A1—epilepsy syndrome	2.77e-05	0.000534	CbGpPWpGaD
Metolazone—CA7—Metabolism—CACNA1A—epilepsy syndrome	2.77e-05	0.000534	CbGpPWpGaD
Metolazone—CA9—Metabolism—GAMT—epilepsy syndrome	2.76e-05	0.000532	CbGpPWpGaD
Metolazone—CA9—Metabolism—EPM2A—epilepsy syndrome	2.76e-05	0.000532	CbGpPWpGaD
Metolazone—CA9—Metabolism—NHLRC1—epilepsy syndrome	2.76e-05	0.000532	CbGpPWpGaD
Metolazone—CA12—Metabolism—STXBP1—epilepsy syndrome	2.76e-05	0.000532	CbGpPWpGaD
Metolazone—CA9—Metabolism—PNPO—epilepsy syndrome	2.76e-05	0.000532	CbGpPWpGaD
Metolazone—Hypersensitivity—Pregabalin—epilepsy syndrome	2.76e-05	0.000289	CcSEcCtD
Metolazone—Anorexia—Topiramate—epilepsy syndrome	2.75e-05	0.000288	CcSEcCtD
Metolazone—Dizziness—Valproic Acid—epilepsy syndrome	2.74e-05	0.000287	CcSEcCtD
Metolazone—CA5A—Metabolism—CACNA1D—epilepsy syndrome	2.74e-05	0.000527	CbGpPWpGaD
Metolazone—Urticaria—Gabapentin—epilepsy syndrome	2.73e-05	0.000285	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—CAT—epilepsy syndrome	2.72e-05	0.000524	CbGpPWpGaD
Metolazone—Abdominal pain—Gabapentin—epilepsy syndrome	2.71e-05	0.000284	CcSEcCtD
Metolazone—CA7—Metabolism—ST3GAL3—epilepsy syndrome	2.71e-05	0.000522	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ST3GAL3—epilepsy syndrome	2.71e-05	0.000522	CbGpPWpGaD
Metolazone—CA12—Metabolism—NT5E—epilepsy syndrome	2.69e-05	0.000518	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALAD—epilepsy syndrome	2.69e-05	0.000518	CbGpPWpGaD
Metolazone—Asthenia—Pregabalin—epilepsy syndrome	2.69e-05	0.000281	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—SIRT1—epilepsy syndrome	2.68e-05	0.000516	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ADSL—epilepsy syndrome	2.66e-05	0.000512	CbGpPWpGaD
Metolazone—CA7—Metabolism—ADSL—epilepsy syndrome	2.66e-05	0.000512	CbGpPWpGaD
Metolazone—Pruritus—Pregabalin—epilepsy syndrome	2.65e-05	0.000277	CcSEcCtD
Metolazone—Vomiting—Valproic Acid—epilepsy syndrome	2.63e-05	0.000276	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.63e-05	0.000275	CcSEcCtD
Metolazone—Insomnia—Topiramate—epilepsy syndrome	2.61e-05	0.000273	CcSEcCtD
Metolazone—Rash—Valproic Acid—epilepsy syndrome	2.61e-05	0.000273	CcSEcCtD
Metolazone—Dermatitis—Valproic Acid—epilepsy syndrome	2.61e-05	0.000273	CcSEcCtD
Metolazone—CA5B—Metabolism—GLUL—epilepsy syndrome	2.6e-05	0.000502	CbGpPWpGaD
Metolazone—CA7—Metabolism—GLUL—epilepsy syndrome	2.6e-05	0.000502	CbGpPWpGaD
Metolazone—Headache—Valproic Acid—epilepsy syndrome	2.59e-05	0.000271	CcSEcCtD
Metolazone—Paraesthesia—Topiramate—epilepsy syndrome	2.59e-05	0.000271	CcSEcCtD
Metolazone—SLC12A3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.59e-05	0.000499	CbGpPWpGaD
Metolazone—CA4—Metabolism—NEU1—epilepsy syndrome	2.59e-05	0.000499	CbGpPWpGaD
Metolazone—CA4—Metabolism—ATIC—epilepsy syndrome	2.59e-05	0.000499	CbGpPWpGaD
Metolazone—CA4—Metabolism—UPB1—epilepsy syndrome	2.59e-05	0.000499	CbGpPWpGaD
Metolazone—Somnolence—Topiramate—epilepsy syndrome	2.57e-05	0.000269	CcSEcCtD
Metolazone—CA12—Metabolism—ALDH7A1—epilepsy syndrome	2.57e-05	0.000494	CbGpPWpGaD
Metolazone—CA9—Metabolism—QDPR—epilepsy syndrome	2.57e-05	0.000494	CbGpPWpGaD
Metolazone—CA9—Metabolism—CA4—epilepsy syndrome	2.57e-05	0.000494	CbGpPWpGaD
Metolazone—CA12—Metabolism—CACNA1A—epilepsy syndrome	2.57e-05	0.000494	CbGpPWpGaD
Metolazone—Diarrhoea—Pregabalin—epilepsy syndrome	2.56e-05	0.000268	CcSEcCtD
Metolazone—CA5A—Metabolism—TXNRD1—epilepsy syndrome	2.56e-05	0.000493	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CACNA1D—epilepsy syndrome	2.56e-05	0.000492	CbGpPWpGaD
Metolazone—CA7—Metabolism—CACNA1D—epilepsy syndrome	2.56e-05	0.000492	CbGpPWpGaD
Metolazone—Dyspepsia—Topiramate—epilepsy syndrome	2.54e-05	0.000266	CcSEcCtD
Metolazone—Hypersensitivity—Gabapentin—epilepsy syndrome	2.53e-05	0.000265	CcSEcCtD
Metolazone—CA12—Metabolism—ST3GAL3—epilepsy syndrome	2.51e-05	0.000484	CbGpPWpGaD
Metolazone—Decreased appetite—Topiramate—epilepsy syndrome	2.51e-05	0.000263	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—H2AFX—epilepsy syndrome	2.5e-05	0.000482	CbGpPWpGaD
Metolazone—CA4—Metabolism—HSD17B4—epilepsy syndrome	2.49e-05	0.00048	CbGpPWpGaD
Metolazone—Fatigue—Topiramate—epilepsy syndrome	2.49e-05	0.000261	CcSEcCtD
Metolazone—CA5A—Metabolism—AQP1—epilepsy syndrome	2.49e-05	0.000479	CbGpPWpGaD
Metolazone—Dizziness—Pregabalin—epilepsy syndrome	2.48e-05	0.000259	CcSEcCtD
Metolazone—SLC12A3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.47e-05	0.000476	CbGpPWpGaD
Metolazone—Constipation—Topiramate—epilepsy syndrome	2.47e-05	0.000258	CcSEcCtD
Metolazone—Pain—Topiramate—epilepsy syndrome	2.47e-05	0.000258	CcSEcCtD
Metolazone—Asthenia—Gabapentin—epilepsy syndrome	2.46e-05	0.000258	CcSEcCtD
Metolazone—CA12—Metabolism—ADSL—epilepsy syndrome	2.46e-05	0.000474	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—GPX1—epilepsy syndrome	2.46e-05	0.000474	CbGpPWpGaD
Metolazone—Nausea—Valproic Acid—epilepsy syndrome	2.46e-05	0.000257	CcSEcCtD
Metolazone—Pruritus—Gabapentin—epilepsy syndrome	2.43e-05	0.000254	CcSEcCtD
Metolazone—CA12—Metabolism—GLUL—epilepsy syndrome	2.41e-05	0.000465	CbGpPWpGaD
Metolazone—CA9—Metabolism—COX3—epilepsy syndrome	2.41e-05	0.000465	CbGpPWpGaD
Metolazone—CA4—Metabolism—GBE1—epilepsy syndrome	2.41e-05	0.000464	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPP1R3C—epilepsy syndrome	2.41e-05	0.000464	CbGpPWpGaD
Metolazone—SLC12A3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.4e-05	0.000463	CbGpPWpGaD
Metolazone—CA7—Metabolism—TXNRD1—epilepsy syndrome	2.39e-05	0.000461	CbGpPWpGaD
Metolazone—CA5B—Metabolism—TXNRD1—epilepsy syndrome	2.39e-05	0.000461	CbGpPWpGaD
Metolazone—Vomiting—Pregabalin—epilepsy syndrome	2.38e-05	0.000249	CcSEcCtD
Metolazone—Feeling abnormal—Topiramate—epilepsy syndrome	2.38e-05	0.000249	CcSEcCtD
Metolazone—CA12—Metabolism—CACNA1D—epilepsy syndrome	2.37e-05	0.000456	CbGpPWpGaD
Metolazone—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.36e-05	0.000247	CcSEcCtD
Metolazone—Rash—Pregabalin—epilepsy syndrome	2.36e-05	0.000247	CcSEcCtD
Metolazone—Dermatitis—Pregabalin—epilepsy syndrome	2.36e-05	0.000247	CcSEcCtD
Metolazone—Diarrhoea—Gabapentin—epilepsy syndrome	2.35e-05	0.000246	CcSEcCtD
Metolazone—Headache—Pregabalin—epilepsy syndrome	2.34e-05	0.000245	CcSEcCtD
Metolazone—CA5B—Metabolism—AQP1—epilepsy syndrome	2.32e-05	0.000447	CbGpPWpGaD
Metolazone—CA7—Metabolism—AQP1—epilepsy syndrome	2.32e-05	0.000447	CbGpPWpGaD
Metolazone—Urticaria—Topiramate—epilepsy syndrome	2.29e-05	0.00024	CcSEcCtD
Metolazone—CA9—Metabolism—KCNB1—epilepsy syndrome	2.29e-05	0.000441	CbGpPWpGaD
Metolazone—CA9—Metabolism—CACNA2D2—epilepsy syndrome	2.29e-05	0.000441	CbGpPWpGaD
Metolazone—CA9—Metabolism—PFKL—epilepsy syndrome	2.29e-05	0.000441	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLCO1A2—epilepsy syndrome	2.29e-05	0.000441	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC6A8—epilepsy syndrome	2.29e-05	0.000441	CbGpPWpGaD
Metolazone—Abdominal pain—Topiramate—epilepsy syndrome	2.28e-05	0.000239	CcSEcCtD
Metolazone—Dizziness—Gabapentin—epilepsy syndrome	2.27e-05	0.000238	CcSEcCtD
Metolazone—CA4—Metabolism—ASAH1—epilepsy syndrome	2.26e-05	0.000436	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CHRM3—epilepsy syndrome	2.25e-05	0.000433	CbGpPWpGaD
Metolazone—CA5A—Metabolism—KCNJ11—epilepsy syndrome	2.25e-05	0.000433	CbGpPWpGaD
Metolazone—Nausea—Pregabalin—epilepsy syndrome	2.22e-05	0.000233	CcSEcCtD
Metolazone—CA12—Metabolism—TXNRD1—epilepsy syndrome	2.21e-05	0.000427	CbGpPWpGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	2.21e-05	0.000425	CbGpPWpGaD
Metolazone—CA4—Metabolism—STXBP1—epilepsy syndrome	2.2e-05	0.000424	CbGpPWpGaD
Metolazone—Vomiting—Gabapentin—epilepsy syndrome	2.18e-05	0.000228	CcSEcCtD
Metolazone—Rash—Gabapentin—epilepsy syndrome	2.16e-05	0.000226	CcSEcCtD
Metolazone—Dermatitis—Gabapentin—epilepsy syndrome	2.16e-05	0.000226	CcSEcCtD
Metolazone—Headache—Gabapentin—epilepsy syndrome	2.15e-05	0.000225	CcSEcCtD
Metolazone—CA12—Metabolism—AQP1—epilepsy syndrome	2.15e-05	0.000414	CbGpPWpGaD
Metolazone—CA4—Metabolism—NT5E—epilepsy syndrome	2.14e-05	0.000413	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALAD—epilepsy syndrome	2.14e-05	0.000413	CbGpPWpGaD
Metolazone—Hypersensitivity—Topiramate—epilepsy syndrome	2.13e-05	0.000223	CcSEcCtD
Metolazone—CA7—Metabolism—KCNJ11—epilepsy syndrome	2.1e-05	0.000404	CbGpPWpGaD
Metolazone—CA5B—Metabolism—KCNJ11—epilepsy syndrome	2.1e-05	0.000404	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CHRM3—epilepsy syndrome	2.1e-05	0.000404	CbGpPWpGaD
Metolazone—CA7—Metabolism—CHRM3—epilepsy syndrome	2.1e-05	0.000404	CbGpPWpGaD
Metolazone—CA9—Metabolism—UPB1—epilepsy syndrome	2.09e-05	0.000403	CbGpPWpGaD
Metolazone—CA9—Metabolism—ATIC—epilepsy syndrome	2.09e-05	0.000403	CbGpPWpGaD
Metolazone—CA9—Metabolism—NEU1—epilepsy syndrome	2.09e-05	0.000403	CbGpPWpGaD
Metolazone—Asthenia—Topiramate—epilepsy syndrome	2.07e-05	0.000217	CcSEcCtD
Metolazone—CA4—Metabolism—ALDH7A1—epilepsy syndrome	2.05e-05	0.000394	CbGpPWpGaD
Metolazone—CA4—Metabolism—CACNA1A—epilepsy syndrome	2.05e-05	0.000394	CbGpPWpGaD
Metolazone—Pruritus—Topiramate—epilepsy syndrome	2.04e-05	0.000214	CcSEcCtD
Metolazone—Nausea—Gabapentin—epilepsy syndrome	2.04e-05	0.000213	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—ATM—epilepsy syndrome	2.03e-05	0.000392	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.03e-05	0.000392	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.02e-05	0.000388	CbGpPWpGaD
Metolazone—CA9—Metabolism—HSD17B4—epilepsy syndrome	2.01e-05	0.000388	CbGpPWpGaD
Metolazone—CA4—Metabolism—ST3GAL3—epilepsy syndrome	2e-05	0.000386	CbGpPWpGaD
Metolazone—Diarrhoea—Topiramate—epilepsy syndrome	1.98e-05	0.000207	CcSEcCtD
Metolazone—CA4—Metabolism—ADSL—epilepsy syndrome	1.96e-05	0.000378	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.95e-05	0.000376	CbGpPWpGaD
Metolazone—CA12—Metabolism—CHRM3—epilepsy syndrome	1.94e-05	0.000375	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPP1R3C—epilepsy syndrome	1.94e-05	0.000375	CbGpPWpGaD
Metolazone—CA9—Metabolism—GBE1—epilepsy syndrome	1.94e-05	0.000375	CbGpPWpGaD
Metolazone—CA12—Metabolism—KCNJ11—epilepsy syndrome	1.94e-05	0.000375	CbGpPWpGaD
Metolazone—CA4—Metabolism—GLUL—epilepsy syndrome	1.92e-05	0.000371	CbGpPWpGaD
Metolazone—Dizziness—Topiramate—epilepsy syndrome	1.91e-05	0.0002	CcSEcCtD
Metolazone—CA4—Metabolism—CACNA1D—epilepsy syndrome	1.89e-05	0.000364	CbGpPWpGaD
Metolazone—Vomiting—Topiramate—epilepsy syndrome	1.84e-05	0.000192	CcSEcCtD
Metolazone—CA5A—Metabolism—ABCG2—epilepsy syndrome	1.83e-05	0.000353	CbGpPWpGaD
Metolazone—CA9—Metabolism—ASAH1—epilepsy syndrome	1.83e-05	0.000352	CbGpPWpGaD
Metolazone—Rash—Topiramate—epilepsy syndrome	1.82e-05	0.000191	CcSEcCtD
Metolazone—Dermatitis—Topiramate—epilepsy syndrome	1.82e-05	0.00019	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—FOS—epilepsy syndrome	1.82e-05	0.00035	CbGpPWpGaD
Metolazone—Headache—Topiramate—epilepsy syndrome	1.81e-05	0.000189	CcSEcCtD
Metolazone—CA5A—Metabolism—CYP2C19—epilepsy syndrome	1.79e-05	0.000344	CbGpPWpGaD
Metolazone—CA9—Metabolism—STXBP1—epilepsy syndrome	1.78e-05	0.000343	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP11A1—epilepsy syndrome	1.77e-05	0.000342	CbGpPWpGaD
Metolazone—CA4—Metabolism—TXNRD1—epilepsy syndrome	1.77e-05	0.00034	CbGpPWpGaD
Metolazone—CA9—Metabolism—NT5E—epilepsy syndrome	1.73e-05	0.000334	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALAD—epilepsy syndrome	1.73e-05	0.000334	CbGpPWpGaD
Metolazone—Nausea—Topiramate—epilepsy syndrome	1.72e-05	0.00018	CcSEcCtD
Metolazone—CA4—Metabolism—AQP1—epilepsy syndrome	1.71e-05	0.00033	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCG2—epilepsy syndrome	1.71e-05	0.00033	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCG2—epilepsy syndrome	1.71e-05	0.00033	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP2C19—epilepsy syndrome	1.67e-05	0.000321	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP2C19—epilepsy syndrome	1.67e-05	0.000321	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP11A1—epilepsy syndrome	1.66e-05	0.000319	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP11A1—epilepsy syndrome	1.66e-05	0.000319	CbGpPWpGaD
Metolazone—CA9—Metabolism—CACNA1A—epilepsy syndrome	1.65e-05	0.000319	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALDH7A1—epilepsy syndrome	1.65e-05	0.000319	CbGpPWpGaD
Metolazone—CA9—Metabolism—ST3GAL3—epilepsy syndrome	1.62e-05	0.000312	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP2D6—epilepsy syndrome	1.6e-05	0.000309	CbGpPWpGaD
Metolazone—CA9—Metabolism—ADSL—epilepsy syndrome	1.59e-05	0.000305	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCG2—epilepsy syndrome	1.59e-05	0.000305	CbGpPWpGaD
Metolazone—CA9—Metabolism—GLUL—epilepsy syndrome	1.55e-05	0.0003	CbGpPWpGaD
Metolazone—CA4—Metabolism—KCNJ11—epilepsy syndrome	1.55e-05	0.000299	CbGpPWpGaD
Metolazone—CA4—Metabolism—CHRM3—epilepsy syndrome	1.55e-05	0.000299	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP2C19—epilepsy syndrome	1.54e-05	0.000298	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP11A1—epilepsy syndrome	1.54e-05	0.000296	CbGpPWpGaD
Metolazone—CA9—Metabolism—CACNA1D—epilepsy syndrome	1.53e-05	0.000294	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ADRA2A—epilepsy syndrome	1.52e-05	0.000294	CbGpPWpGaD
Metolazone—CA5A—Metabolism—BCHE—epilepsy syndrome	1.52e-05	0.000293	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP2D6—epilepsy syndrome	1.5e-05	0.000288	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP2D6—epilepsy syndrome	1.5e-05	0.000288	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—RELA—epilepsy syndrome	1.49e-05	0.000287	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MTOR—epilepsy syndrome	1.46e-05	0.000282	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SLC2A1—epilepsy syndrome	1.45e-05	0.000279	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PLCB1—epilepsy syndrome	1.43e-05	0.000276	CbGpPWpGaD
Metolazone—CA5A—Metabolism—TH—epilepsy syndrome	1.43e-05	0.000275	CbGpPWpGaD
Metolazone—CA9—Metabolism—TXNRD1—epilepsy syndrome	1.43e-05	0.000275	CbGpPWpGaD
Metolazone—CA7—Metabolism—ADRA2A—epilepsy syndrome	1.42e-05	0.000274	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ADRA2A—epilepsy syndrome	1.42e-05	0.000274	CbGpPWpGaD
Metolazone—CA5B—Metabolism—BCHE—epilepsy syndrome	1.42e-05	0.000273	CbGpPWpGaD
Metolazone—CA7—Metabolism—BCHE—epilepsy syndrome	1.42e-05	0.000273	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP2D6—epilepsy syndrome	1.39e-05	0.000267	CbGpPWpGaD
Metolazone—CA9—Metabolism—AQP1—epilepsy syndrome	1.39e-05	0.000267	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC2A1—epilepsy syndrome	1.35e-05	0.000261	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC2A1—epilepsy syndrome	1.35e-05	0.000261	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PLCB1—epilepsy syndrome	1.34e-05	0.000258	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLCB1—epilepsy syndrome	1.34e-05	0.000258	CbGpPWpGaD
Metolazone—CA5B—Metabolism—TH—epilepsy syndrome	1.33e-05	0.000257	CbGpPWpGaD
Metolazone—CA7—Metabolism—TH—epilepsy syndrome	1.33e-05	0.000257	CbGpPWpGaD
Metolazone—CA12—Metabolism—ADRA2A—epilepsy syndrome	1.32e-05	0.000254	CbGpPWpGaD
Metolazone—CA12—Metabolism—BCHE—epilepsy syndrome	1.31e-05	0.000253	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—JUN—epilepsy syndrome	1.31e-05	0.000252	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCG2—epilepsy syndrome	1.26e-05	0.000244	CbGpPWpGaD
Metolazone—CA9—Metabolism—KCNJ11—epilepsy syndrome	1.25e-05	0.000241	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC2A1—epilepsy syndrome	1.25e-05	0.000241	CbGpPWpGaD
Metolazone—CA9—Metabolism—CHRM3—epilepsy syndrome	1.25e-05	0.000241	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLCB1—epilepsy syndrome	1.24e-05	0.000239	CbGpPWpGaD
Metolazone—CA12—Metabolism—TH—epilepsy syndrome	1.23e-05	0.000238	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2C19—epilepsy syndrome	1.23e-05	0.000237	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP11A1—epilepsy syndrome	1.22e-05	0.000236	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.22e-05	0.000235	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HMOX1—epilepsy syndrome	1.19e-05	0.00023	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CAT—epilepsy syndrome	1.18e-05	0.000227	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCB1—epilepsy syndrome	1.14e-05	0.00022	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—epilepsy syndrome	1.14e-05	0.00022	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMOX1—epilepsy syndrome	1.11e-05	0.000214	CbGpPWpGaD
Metolazone—CA7—Metabolism—HMOX1—epilepsy syndrome	1.11e-05	0.000214	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2D6—epilepsy syndrome	1.1e-05	0.000213	CbGpPWpGaD
Metolazone—CA7—Metabolism—CAT—epilepsy syndrome	1.1e-05	0.000211	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CAT—epilepsy syndrome	1.1e-05	0.000211	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCB1—epilepsy syndrome	1.07e-05	0.000206	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCB1—epilepsy syndrome	1.07e-05	0.000206	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GPX1—epilepsy syndrome	1.06e-05	0.000205	CbGpPWpGaD
Metolazone—CA4—Metabolism—ADRA2A—epilepsy syndrome	1.05e-05	0.000203	CbGpPWpGaD
Metolazone—CA4—Metabolism—BCHE—epilepsy syndrome	1.05e-05	0.000202	CbGpPWpGaD
Metolazone—CA12—Metabolism—HMOX1—epilepsy syndrome	1.03e-05	0.000199	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG2—epilepsy syndrome	1.02e-05	0.000197	CbGpPWpGaD
Metolazone—CA12—Metabolism—CAT—epilepsy syndrome	1.02e-05	0.000196	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC2A1—epilepsy syndrome	9.99e-06	0.000193	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2C19—epilepsy syndrome	9.95e-06	0.000192	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GPX1—epilepsy syndrome	9.93e-06	0.000191	CbGpPWpGaD
Metolazone—CA7—Metabolism—GPX1—epilepsy syndrome	9.93e-06	0.000191	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCB1—epilepsy syndrome	9.89e-06	0.000191	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP11A1—epilepsy syndrome	9.89e-06	0.000191	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLCB1—epilepsy syndrome	9.88e-06	0.00019	CbGpPWpGaD
Metolazone—CA4—Metabolism—TH—epilepsy syndrome	9.85e-06	0.00019	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AGT—epilepsy syndrome	9.32e-06	0.00018	CbGpPWpGaD
Metolazone—CA12—Metabolism—GPX1—epilepsy syndrome	9.2e-06	0.000177	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOE—epilepsy syndrome	9.14e-06	0.000176	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2D6—epilepsy syndrome	8.93e-06	0.000172	CbGpPWpGaD
Metolazone—CA7—Metabolism—AGT—epilepsy syndrome	8.7e-06	0.000168	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AGT—epilepsy syndrome	8.7e-06	0.000168	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOE—epilepsy syndrome	8.53e-06	0.000164	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOE—epilepsy syndrome	8.53e-06	0.000164	CbGpPWpGaD
Metolazone—CA9—Metabolism—ADRA2A—epilepsy syndrome	8.5e-06	0.000164	CbGpPWpGaD
Metolazone—CA9—Metabolism—BCHE—epilepsy syndrome	8.46e-06	0.000163	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMOX1—epilepsy syndrome	8.22e-06	0.000158	CbGpPWpGaD
Metolazone—CA4—Metabolism—CAT—epilepsy syndrome	8.11e-06	0.000156	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC2A1—epilepsy syndrome	8.07e-06	0.000156	CbGpPWpGaD
Metolazone—CA12—Metabolism—AGT—epilepsy syndrome	8.06e-06	0.000155	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLCB1—epilepsy syndrome	7.99e-06	0.000154	CbGpPWpGaD
Metolazone—CA9—Metabolism—TH—epilepsy syndrome	7.96e-06	0.000153	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOE—epilepsy syndrome	7.9e-06	0.000152	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCB1—epilepsy syndrome	7.89e-06	0.000152	CbGpPWpGaD
Metolazone—CA5A—Metabolism—POMC—epilepsy syndrome	7.85e-06	0.000151	CbGpPWpGaD
Metolazone—CA4—Metabolism—GPX1—epilepsy syndrome	7.33e-06	0.000141	CbGpPWpGaD
Metolazone—CA7—Metabolism—POMC—epilepsy syndrome	7.33e-06	0.000141	CbGpPWpGaD
Metolazone—CA5B—Metabolism—POMC—epilepsy syndrome	7.33e-06	0.000141	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALB—epilepsy syndrome	7.15e-06	0.000138	CbGpPWpGaD
Metolazone—CA12—Metabolism—POMC—epilepsy syndrome	6.79e-06	0.000131	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALB—epilepsy syndrome	6.68e-06	0.000129	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALB—epilepsy syndrome	6.68e-06	0.000129	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMOX1—epilepsy syndrome	6.64e-06	0.000128	CbGpPWpGaD
Metolazone—CA9—Metabolism—CAT—epilepsy syndrome	6.55e-06	0.000126	CbGpPWpGaD
Metolazone—CA4—Metabolism—AGT—epilepsy syndrome	6.43e-06	0.000124	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCB1—epilepsy syndrome	6.37e-06	0.000123	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOE—epilepsy syndrome	6.3e-06	0.000121	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—epilepsy syndrome	6.26e-06	0.000121	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALB—epilepsy syndrome	6.19e-06	0.000119	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX1—epilepsy syndrome	5.93e-06	0.000114	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—epilepsy syndrome	5.84e-06	0.000113	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—epilepsy syndrome	5.84e-06	0.000113	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—epilepsy syndrome	5.41e-06	0.000104	CbGpPWpGaD
Metolazone—CA4—Metabolism—POMC—epilepsy syndrome	5.41e-06	0.000104	CbGpPWpGaD
Metolazone—CA9—Metabolism—AGT—epilepsy syndrome	5.2e-06	0.0001	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOE—epilepsy syndrome	5.09e-06	9.81e-05	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALB—epilepsy syndrome	4.93e-06	9.51e-05	CbGpPWpGaD
Metolazone—CA9—Metabolism—POMC—epilepsy syndrome	4.37e-06	8.43e-05	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—epilepsy syndrome	4.32e-06	8.32e-05	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALB—epilepsy syndrome	3.99e-06	7.68e-05	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—epilepsy syndrome	3.49e-06	6.72e-05	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—epilepsy syndrome	3.15e-06	6.06e-05	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—epilepsy syndrome	2.94e-06	5.66e-05	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—epilepsy syndrome	2.94e-06	5.66e-05	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—epilepsy syndrome	2.72e-06	5.24e-05	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—epilepsy syndrome	2.17e-06	4.18e-05	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—epilepsy syndrome	1.75e-06	3.38e-05	CbGpPWpGaD
